Moreover, the geraniin-dependent inhibition of Hsp90α chaperone activity caused a dose-dependent decrease in the level of the oncogenic proteins c-Raf, pAkt and EGFR, further supporting the potential of this compound to interfere with tumor progression. The gene discussed is HSP90AA1; the disease is neoplasm.